Pyruvate kinase activators for use in therapy
US-9193701-B2 · Nov 24, 2015 · US
US8993596B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8993596-B2 |
| Application number | US-201414469199-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 29, 2014 |
| Priority date | Dec 2, 2008 |
| Publication date | Mar 31, 2015 |
| Grant date | Mar 31, 2015 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
4-(Azacycloalkyl)benzene-1,3-diol compounds are described corresponding to general formula (I) below: Also described, are compositions including the same, processes for preparation thereof and uses thereof in pharmaceutical or cosmetic compositions to treat pigmentary disorders.
Opening claim text (preview).
What is claimed is: 1. A pharmaceutical or cosmetic composition comprising a compound of formula (I) below: in which: R1 represents: a C 1 -C 5 alkyl radical, a C 3 -C 5 cycloalkyl radical, an aryl radical, a substituted aryl radical, an aralkyl radical, a C 1 -C 5 alkoxy radical, an amino radical corresponding to structure (a):…
Human Necessities · mapped topic
Human Necessities · mapped topic
Chemistry & Metallurgy · mapped topic
Chemistry & Metallurgy · mapped topic
Human Necessities · mapped topic
Related publications grouped by family.
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Answers are generated from the same data shown on this page.